SCHEMBL7654696

SCHEMBL7654696

CCCCNC(=O)Oc1ccc2c(c1)C(=O)C(CC1CCNCC1)C2

nearest known ligand 0.49

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ACHE P22303 17/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7652169 0.83 BCHE (0.56) ACHE
SCHEMBL7677099 0.81 METAP1 (0.40) ACHE
SCHEMBL4843083 0.78 METAP1 (0.58) ACHE
SCHEMBL4834272 0.69 METAP1 (0.60) ACHE
SCHEMBL9581596 0.69 BCHE (0.62) ACHE
SCHEMBL11668425 0.67 MGLL (0.77)
SCHEMBL12306069 0.67 ACHE (0.44) ACHE
SCHEMBL4198622 0.67 ACHE (0.56) ACHE
Acetic Acid SCHEMBL29374009 0.67 ACHE (0.60) ACHE
Acetic Acid SCHEMBL27493902 0.67 ACHE (0.60) ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6413986-B1 ALZHEIMER'S DISEASE AVENTIS PHARMACEUTICALS INC. 2002-07-02 US claimed
US-6413986-B1 ALZHEIMER'S DISEASE AVENTIS PHARMACEUTICALS INC. 2002-07-02 US disclosed
EP-0535496-A1 (1-Indanon-2yl)methylpiperidines, intermediates and a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-04-07 EP disclosed